Skip to content
OpenCapital
Get started

Zoetis ZTS Animal health diagnostics — Revenue

Other product segments

Horses
$5.8B+13.9%
Dogs and Cats
$1.35B+11.6%
Parasiticides
$586M+2.4%
Vaccines
$519M+18.2%
Cattle
$399M-0.5%
Dermatology
$349M-7.9%
Anti-infectives
$241M+1.3%
Pain and sedation
$203M-1.9%
Other pharmaceutical
$158M0.0%
Swine
$128M-7.9%
Poultry
$117M-7.9%
Other Non Pharmaceuticals
$66M-7.0%
Fish
$65M+4.8%
Contract manufacturing & human health
$23M-23.3%
Sheep and other
$17M+6.3%

Similar metrics at other companies

Idexx Laboratories logo
IDXXCAG Diagnostics services and accessories — Total Revenue
$1.14B+14.3%
Cencora logo
CORAnimal Health — Revenue
$1.44B+5.3%
Phibro Animal Health logo
PAHCAnimal Health — Revenue
$291.23M+12.7%
Idexx Laboratories logo
IDXXCAG Diagnostics services and accessories — Revenue
$36.61M+10.8%
Idexx Laboratories logo
IDXXRapid assay products — Total Revenue
$84.94M+1.1%
Idexx Laboratories logo
IDXXCAG Diagnostics capital - instruments — Total Revenue
$42.45M+32.7%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's animal health diagnostics — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's animal health diagnostics — revenue?
Zoetis (ZTS) reported animal health diagnostics — revenue of $117M in Q1 2026.
How has Zoetis's animal health diagnostics — revenue changed year-over-year?
Zoetis's animal health diagnostics — revenue increased by 12.5% year-over-year, from $104M to $117M.
What is the long-term trend for Zoetis's animal health diagnostics — revenue?
Over 4 years (2021 to 2025), Zoetis's animal health diagnostics — revenue has grown at a 3.8% compound annual growth rate (CAGR), from $374M to $435M.
What does animal health diagnostics — revenue mean?
This metric represents the total net sales generated from the sale of diagnostic instruments, testing kits, and related laboratory services designed for animal health. It reflects the company's ability to monetize clinical decision-support tools used by veterinarians to detect, diagnose, and monitor diseases in companion and production animals. As a critical component of the broader animal health portfolio, this revenue stream indicates the firm's penetration into the clinical diagnostics market and its success in driving recurring revenue through consumable testing products.